Skip to main content
. Author manuscript; available in PMC: 2021 Nov 9.
Published in final edited form as: Circ Cardiovasc Imaging. 2020 Nov 9;13(11):e011925. doi: 10.1161/CIRCIMAGING.120.011925

Table 1.

Baseline Characteristics by Quartile of FGF23.

Characteristic FGF23
Quartile 1
(n=568)
FGF23
Quartile 2
(n=570)
FGF23
Quartile 3
(n=569)
FGF23
Quartile 4
(n=569)
P value
(linear trend)
Age, y, mean±SD 58.7±9.2 59.4±9.1 59.0±9.4 60.1±9.5 0.06
Female, n (%) 329 (57.9) 300 (52.6) 295 (51.9) 308 (54.1) 0.17
Race, n (%) 0.04
 Black 139 (24.5) 137 (24.0) 133 (23.4) 119 (20.9)
 Chinese 78 (13.7) 83 (14.6) 69 (12.1) 70 (12.3)
 Hispanic 135 (23.8) 115 (20.2) 117 (20.6) 100 (17.6)
 White 216 (38.0) 235 (41.2) 250 (43.9) 280 (49.2)
Current Smoker, n (%) 86 (15.2) 48 (8.4) 55 (9.7) 45 (7.9) 0.001
Body mass index, kg/m2, mean ± SD 27.0±4.8 27.4±4.9 27.5±4.8 28.4±5.2 <0.001
Systolic blood pressure, mmHg, mean ± SD 122.2±21.3 121.8±19.7 121.9±19.4 123.7±19.2 0.37
Anti-hypertensive medication, n (%) 129 (22.7) 142 (24.9) 144 (25.3) 194 (34.1) <0.001
Diabetes mellitus, n (%) 39 (6.9) 53 (9.3) 48 (8.5) 59 (10.4) 0.20
Total cholesterol, mg/dL, mean ± SD 194.6±35.4 194.4±33.2 195.7±36.6 195.3±36.1 0.93
LDL cholesterol, mg/dL, mean ± SD 116.8±31.9 118.1±31.1 118.7±31.6 117.8±31.3 0.78
Glucose, mg/dL, median (IQR) 87 (81–96) 88 (82–95) 87 (82–96) 88 (83–96) 0.95
eGFR mL/min/1.73 m2, mean ± SD 83.8±14.4 80.4±13.8 79.8±14.6 74.6±15.6 <0.001
Calcium, mg/dL, mean ± SD 9.6±0.4 9.6±0.4 9.7±0.4 9.7±0.4 0.003
25- hydroxyvitamin D, ng/mL, mean ± SD 24.9±12.5 25.7±11.2 26.6±11.3 27.6±11.2 <0.001
Phosphate, urine, mg/dL, mean ± SD 47.3±31.8 48.5±31.1 51.2±37.1 54.9±41.7 0.002
Parathyroid hormone, pg/mL, mean ±SD 42.1±18.2 41.8±17.1 42.4±18.1 42.7±18.1 0.86
Angiotensin converting enzyme inhibitor, n (%) 50 (8.8) 53 (9.3) 51 (9.0) 66 (11.6) 0.34
Angiotensin receptor blocker, n(%) 15 (2.7) 23 (4.1) 18 (3.2) 39 (6.9) 0.002

FGF23 = fibroblast growth factor 23; eGFR = estimated glomerular filtration rate; LDL = low-density lipoprotein